In studying the regulation of the stress activated kinases (JNKs) in cells maintained under normal growth conditions, the applicant identified a 23 kD protein which inhibits JNK activities through its association with the JNK-jun complex (but not with the individual components). Microsequencing of this biochemically purified JNK inhibitor identified glutathione-S-transferase pi as the inhibitory component. The finding of GSTpi as the JNK inhibitor was confirmed through in vitro and in vivo experiments using purified GSTpi, its respective cDNA, and specific GSTpi inhibitors. In recognizing the link between changes in redox potential and GSTpi, the applicant hypothesizes that, by means of its response to cellular redox potential and its regulation of JNK activity, GST pi is a key regulator of the cell s response to stress. This hypothesis is to be tested by comprehensively characterizing the GSTpi activities as the JNK inhibitor, and by elucidating GSTpi s effect on cellular phenotypes such as drug resistance or apoptosis via its regulation of JNK signaling. Specifically, the applicant will 1) characterize the nature of the GSTpi inhibition of JNK; 2) identify peptides that can modulate GSTpi as the JNK inhibitor; 3) characterize GSTpi as a sensor of redox changes in JNK signaling; 4) determine, using selective peptides identified in earlier aims, the ability to alter apoptosis and drug resistance in MCF-7 breast cancer cells that express low levels of GSTpi and in adriamycin-resistant MCF-7 cells that express 20-30 fold higher levels of GSTpi; and 5) determine the specificity of GSTpi inhibitory activity for other kinases involved in the stress response. Overall, the proposed studies will provide novel therapeutic targets based on new understanding of JNK regulation by GSTpi and its implications regarding key cellular end points, including apoptosis and drug resistance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA077389-01
Application #
2591079
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Johnson, George S
Project Start
1998-04-01
Project End
2002-01-31
Budget Start
1998-04-01
Budget End
1999-01-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Habelhah, Hasem; Frew, Ian J; Laine, Aaron et al. (2002) Stress-induced decrease in TRAF2 stability is mediated by Siah2. EMBO J 21:5756-65
Wang, T; Arifoglu, P; Ronai, Z et al. (2001) Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276:20999-1003
Ruscoe, J E; Rosario, L A; Wang, T et al. (2001) Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298:339-45
Yin, Z; Ivanov, V N; Habelhah, H et al. (2000) Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60:4053-7
Adler, V; Yin, Z; Fuchs, S Y et al. (1999) Regulation of JNK signaling by GSTp. EMBO J 18:1321-34
Adler, V; Yin, Z; Tew, K D et al. (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18:6104-11